Home » Topics » Regulatory

Regulatory
RSS

Two research teams reach the same conclusion: topiramate is a promising antimigraine agent

June 17, 1999

Leukotriene antagonist effective and well tolerated as migraine prophylaxis

June 16, 1999

Isoprinosine as a potential treatment for chronic fatigue syndrome

June 16, 1999

MORE trial results: raloxifene prevents breast cancer in postmenopausal women

June 16, 1999

Tacrine may reduce symptoms of Tourette syndrome

June 16, 1999

Bisoprolol receives first European approval for chronic heart failure

June 15, 1999

Lamictal approved in Canada for Lennox-Gastaut syndrome

June 15, 1999

Oral vitamin D prohormone cleared by the FDA for secondary hyperparathyroidism

June 11, 1999

ATTRACT trial demonstrates long-term efficacy and safety of Remicade in RA

June 11, 1999

Antidiabetic compound effectively treats obesity in patients with altered glucose metabolism

June 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...